BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9868980)

  • 1. Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications.
    Herman WH; Aubert RE; Engelgau MM; Thompson TJ; Ali MA; Sous ES; Hegazy M; Badran A; Kenny SJ; Gunter EW; Malarcher AM; Brechner RJ; Wetterhall SF; DeStefano F; Smith PJ; Habib M; abd el Shakour S; Ibrahim AS; el Behairy EM
    Diabet Med; 1998 Dec; 15(12):1045-51. PubMed ID: 9868980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the relationships of the glucose tolerance test and the glycated haemoglobin assay with diabetic vascular disease in the community. The Islington Diabetes Survey.
    Jackson CA; Yudkin JS; Forrest RD
    Diabetes Res Clin Pract; 1992 Aug; 17(2):111-23. PubMed ID: 1425145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden and pattern of micro vascular complications in type 2 diabetes in a tertiary health institution in Nigeria.
    Olamoyegun M; Ibraheem W; Iwuala S; Audu M; Kolawole B
    Afr Health Sci; 2015 Dec; 15(4):1136-41. PubMed ID: 26958014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
    Lepore G; Bruttomesso D; Nosari I; Tiengo A; Trevisan R
    Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?
    Bragd J; Adamson U; Bäcklund LB; Lins PE; Moberg E; Oskarsson P
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):612-6. PubMed ID: 18824382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
    Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
    Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for microvascular complications of diabetes among South Indian subjects with type 2 diabetes--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-5.
    Pradeepa R; Anjana RM; Unnikrishnan R; Ganesan A; Mohan V; Rema M
    Diabetes Technol Ther; 2010 Oct; 12(10):755-61. PubMed ID: 20818974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Moram CBM; Salles GF
    Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland.
    Ebeling P; Koivisto VA
    Acta Diabetol; 1997 Mar; 34(1):33-8. PubMed ID: 9134055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in the association of prediabetes and type 2 diabetes with microvascular complications and function: The Maastricht Study.
    de Ritter R; Sep SJS; van der Kallen CJH; van Greevenbroek MMJ; de Jong M; Vos RC; Bots ML; Reulen JPH; Houben AJHM; Webers CAB; Berendschot TTJM; Dagnelie PC; Eussen SJPM; Schram MT; Koster A; Peters SAE; Stehouwer CDA
    Cardiovasc Diabetol; 2021 May; 20(1):102. PubMed ID: 33962619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin-dependent diabetes mellitus:"EURODIAB IDDM Complications Study"--results from the Vienna center].
    Abrahamian H; Hörnlein B; Gurdet C; Willinger C; Zaruba E; Irsigler K
    Wien Klin Wochenschr; 1994; 106(5):136-40. PubMed ID: 8171869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal glycaemic and blood pressure but not lipid targets are related to a lower prevalence of diabetic microvascular complications.
    Bashir M; Elhadd T; Dabbous Z; Gul W; Salameh O; Siddiqui M; Al-Muhannadi H; Petropoulos I; Khan A; Ponirakis G; Malik RA
    Diabetes Metab Syndr; 2021; 15(5):102241. PubMed ID: 34390975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent C-peptide levels and microvascular complications in childhood onset type 1 diabetes of long duration.
    Williams KV; Becker DJ; Orchard TJ; Costacou T
    J Diabetes Complications; 2019 Sep; 33(9):657-661. PubMed ID: 31239235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
    Crook MA; Pickup JC; Lumb PJ; Giorgino F; Webb DJ; Fuller JH;
    Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvascular complications and prevalence of urgency incontinence in Japanese patients with type 2 diabetes mellitus: The dogo study.
    Furukawa S; Sakai T; Niiya T; Miyaoka H; Miyake T; Yamamoto S; Maruyama K; Ueda T; Senba H; Todo Y; Torisu M; Minami H; Onji M; Tanigawa T; Matsuura B; Hiasa Y; Miyake Y
    Neurourol Urodyn; 2016 Nov; 35(8):1024-1027. PubMed ID: 26352009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Chronic Diabetic Complications in Newly Diagnosed versus Known Type 2 Diabetic Subjects in a Sample of Alexandria Population, Egypt.
    Khalil SA; Megallaa MH; Rohoma KH; Guindy MA; Zaki A; Hassanein M; Malaty AH; Ismael HM; Kharboush IF; El Kafash DN; Sallam HN; Desouky IA
    Curr Diabetes Rev; 2019; 15(1):74-83. PubMed ID: 29366422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of glycemic control to diabetic complications and health outcomes.
    Klein R; Klein BE
    Diabetes Care; 1998 Dec; 21 Suppl 3():C39-43. PubMed ID: 9850488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and correlations of early microvascular complications in young type I diabetic patients: role of puberty.
    Bognetti E; Calori G; Meschi F; Macellaro P; Bonfanti R; Chiumello G
    J Pediatr Endocrinol Metab; 1997; 10(6):587-92. PubMed ID: 9467128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes.
    Mäkimattila S; Schlenzka A; Mäntysaari M; Bergholm R; Summanen P; Saar P; Erkkilä H; Yki-Järvinen H
    Diabetes Care; 2000 Nov; 23(11):1686-93. PubMed ID: 11092293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of differing dietary, metabolic, and clinical risk factors with microvascular complications of diabetes: a prevalence study of 503 Mexican type II diabetic subjects. II.
    Paisey RB; Arredondo G; Villalobos A; Lozano O; Guevara L; Kelly S
    Diabetes Care; 1984; 7(5):428-33. PubMed ID: 6499636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.